Regenerative Medicine Solutions Acquires Advanced Healthcare Partners

Regenerative Medicine Solutions (RMS) announced today that it has entered into an agreement to acquire Advanced Healthcare Partners (AHP). The strategy behind the business move was the realignment of resources, and the innovative use of stem cells to treat an array of medical conditions under one roof.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
RMS staff

All AHP and Lung Institute 31 employees are now considered employees of RMS.

Tampa, FL (PRWEB) June 27, 2014

Furthering its goal to restore quality of life to patients with little or no hope of medical improvement, Regenerative Medicine Solutions (RMS) announced today that it has entered into an agreement to acquire Advanced Healthcare Partners (AHP). The strategy behind the business move was the realignment of resources, and the innovative use of stem cells to treat an array of medical conditions under one roof. AHP was a leading healthcare management and consulting company, which owned and operated the Lung Institute.

“We are now ready to continue growing the Lung Institute to be the world leader in the care of patients suffering from lung disease by providing the best option for their treatment,” said Jimmy St. Louis, Chief Executive Officer of RMS. “In order to accomplish this mission, we needed to combine all of our teammates and resources together to focus on one company and one mission, RMS.”

As a leader in regenerative medicine, the Lung Institute utilizes stem cells from the patient’s own body to treat lung disease. These autologous cells work to promote the repair and regeneration of previously damaged lung tissue. RMS is a global provider of stem cell therapy for medical conditions in areas of the body other than the lung.

“All AHP and Lung Institute 31 employees are now considered employees of RMS,” added St. Louis. “With everyone together as one cohesive team, we have tripled our number. We are one team, with one goal: utilization of regenerative medicine to improve the quality of life of our patients from COPD to Crohn’s disease and beyond.”

Together, RMS and the Lung Institute will offer patients access to better care with a staff dedicated to one goal: Improving quality of life in patients. Financial terms of the agreement were not disclosed. RMS has facilities in Tampa and Lima, Peru.

About Regenerative Medicine Solutions
Regenerative Medicine Solutions (RMS) is a leading global provider of innovative regenerative technologies in order to treat an array of debilitating medical conditions. Committed to an individualized patient-centric approach, RMS consistently provides the highest quality of care while producing positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, RMS is changing lives. For more information, visit our website at myregenmed.com, like us on Facebook, or follow us on Twitter or call us today at 1-855-469-5864.

About Lung Institute
Located in Tampa, Florida, the Lung Institute is changing the lives of hundreds of people across the world through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 1-855-4MY-LUNG.


Contact